BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27238851)

  • 1. Hyperthermia , Rhabdomyolysis and Synthetic Cannabinoids - the authors respond.
    Hassen GW; Kalantari H
    Am J Emerg Med; 2016 Aug; 34(8):1691. PubMed ID: 27238851
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthermia and Severe Rhabdomyolysis From Synthetic Cannabinoids Am J Emerg Med 2016;34:121.e1-2. Doi: 10.1016/j.Ajem.2015.05.052. Epub 2015 Jun 12.
    Su M; Laskowski L; Hoffman RS
    Am J Emerg Med; 2016 Aug; 34(8):1690. PubMed ID: 27231136
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids.
    Sweeney B; Talebi S; Toro D; Gonzalez K; Menoscal JP; Shaw R; Hassen GW
    Am J Emerg Med; 2016 Jan; 34(1):121.e1-2. PubMed ID: 26143311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it's not meningitis
    El Zahran T; Gerona R; Morgan BW; Pomerleau AC
    Clin Toxicol (Phila); 2019 Jun; 57(6):421-422. PubMed ID: 30442067
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
    Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
    West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis.
    Whiting D
    Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038
    [No Abstract]   [Full Text] [Related]  

  • 9. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic stroke following use of the synthetic marijuana "spice".
    Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS
    Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia and rhabdomyolysis in an adolescent treated with topiramate and olanzapine.
    Strawn JR; Adler CM; Strakowski SM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):116-8. PubMed ID: 18294095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rhabdomyolysis syndrome and hyperthermia secondary to cocaine and/or ecstasy consumption. Report of 2 new cases and review of the problem].
    Vallina Alvarez E; Suárez Arias R; García Diez A; Arribas Castrillo JM
    An Med Interna; 2002 Feb; 19(2):85-8. PubMed ID: 11989105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment: Spice, reversible cerebral vasoconstriction, and intracranial hemorrhage.
    Barber PA
    Neurology; 2015 Sep; 85(13):1179. PubMed ID: 26320205
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperthermia with acute rhabdomyolysis in a psychotic treated with neuroleptics].
    Reis J; Felten P; Rumbach L; Collard M
    Rev Neurol (Paris); 1983; 139(10):595-6. PubMed ID: 6139869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report].
    Tanei T; Morita Y; Yashima A; Wakita H; Takebayashi S; Nakahara N; Wakabayashi T
    No Shinkei Geka; 2014 Sep; 42(9):867-71. PubMed ID: 25179201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.